CNR Institutional Research Information System

AROSIO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.603
NA - Nord America 1.140
EU - Europa 330
SA - Sud America 296
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 18
OC - Oceania 3
Totale 3.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.073
SG - Singapore 620
CN - Cina 487
BR - Brasile 229
VN - Vietnam 148
HK - Hong Kong 115
KR - Corea 95
IT - Italia 93
FR - Francia 83
CA - Canada 33
JP - Giappone 28
DE - Germania 26
AR - Argentina 24
GB - Regno Unito 22
IN - India 22
NL - Olanda 20
FI - Finlandia 18
BD - Bangladesh 15
CO - Colombia 14
MX - Messico 14
IL - Israele 12
IQ - Iraq 12
ID - Indonesia 11
PL - Polonia 11
ES - Italia 10
TR - Turchia 8
VE - Venezuela 8
EC - Ecuador 7
UA - Ucraina 7
CL - Cile 6
SE - Svezia 6
HU - Ungheria 5
IE - Irlanda 5
ZA - Sudafrica 5
EG - Egitto 4
TH - Thailandia 4
UZ - Uzbekistan 4
BE - Belgio 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HN - Honduras 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
PR - Porto Rico 3
RU - Federazione Russa 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HT - Haiti 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
NO - Norvegia 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 3.391
Salva come PNG Salva come JPEG
Città #
Santa Clara 388
Singapore 333
Hefei 224
Hong Kong 114
San Jose 94
Seoul 93
Ashburn 85
Beijing 76
Lauterbourg 67
Ho Chi Minh City 51
Los Angeles 42
Hanoi 39
Milan 31
São Paulo 16
Minamishinagawa 14
Tokyo 13
Brasília 12
Phoenix 12
Helsinki 11
Rome 11
Atlanta 10
Chicago 10
Dallas 9
Düsseldorf 9
Rio de Janeiro 9
Warsaw 9
Bengaluru 8
Buffalo 8
Brooklyn 7
Frankfurt am Main 7
Houston 7
Lappeenranta 7
New York 7
Ottawa 7
Philadelphia 6
Stockholm 6
Budapest 5
Dublin 5
Haiphong 5
London 5
Montreal 5
Mumbai 5
Quito 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Can Tho 4
Council Bluffs 4
Curitiba 4
Da Nang 4
Johannesburg 4
Juiz de Fora 4
Mexico City 4
Málaga 4
Tashkent 4
Bielefeld 3
Biên Hòa 3
Bodio Lomnago 3
Brookfield 3
Brussels 3
Calgary 3
Cuiabá 3
Detroit 3
Edmonton 3
Goiânia 3
Las Vegas 3
Milwaukee 3
Montevideo 3
Ooltewah 3
Orem 3
Prague 3
Queens 3
Saint Paul 3
Santa Maria 3
Sorocaba 3
St Louis 3
Thu Dau Mot 3
Toronto 3
Akron 2
Alexandria 2
Americana 2
Arlington 2
Bexley 2
Birmingham 2
Bishkek 2
Blytheville 2
Boardman 2
Bogotá 2
Bragança Paulista 2
Buenos Aires 2
Campo Largo 2
Caxias do Sul 2
Charlotte 2
Cincinnati 2
Cleveland 2
Columbus 2
Denver 2
Des Moines 2
Dhaka 2
Elk Grove Village 2
Totale 2.048
Salva come PNG Salva come JPEG
Nome #
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake 95
Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting alphavbeta3/alphavbeta5 integrins and IAP proteins 92
Shifting Towards alpha(V)beta(6)Integrin Ligands Using Novel Aminoproline-Based Cyclic Peptidomimetics 85
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 77
Investigating the Interaction of Cyclic RGD Peptidomimetics with alphaVbeta6 Integrin by Biochemical and Molecular Docking Studies. 76
4-Connected azabicyclo[5.3.0]decane Smac mimetics-Zn2+ chelators as dual action antitumoral agents 74
Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide 73
MicroPET/CT imaging of alphavbeta3 integrin via a novel 68Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction 72
Peptidomimetic compounds and preparation of biologically active derivatives 70
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the ?v?3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis 65
Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose 64
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer 62
Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 61
Trehalose-based neuroprotective autophagy inducers 61
Iron oxide-gold core-shell nanoparticles as multimodal imaging contrast agent 61
Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery 60
Integrin targeted synthetic ligands for diagnostic and therapeutic applications 59
A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts 58
Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability 57
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models 55
Synthesis and preclinical evaluation of a novel, selective 111In-labelled aminoproline-RGD-peptide for non-invasive melanoma tumor imaging 54
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting 51
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 50
Synthesis of Gd and (68) Ga Complexes in Conjugation with a Conformationally Optimized RGD Sequence as Potential MRI and PET Tumor-Imaging Probes 50
RGD Cyclopeptide Equipped with a Lysine-Engaging Salicylaldehyde Showing Enhanced Integrin Affinity and Cell Detachment Potency 49
Novel, soluble 3-heteroaryl-substituted tanshinone mimics attenuate the inflammatory response in murine macrophages 48
Preparation of cyclic RGD peptidomimetic-paclitaxel conjugates targeting integrin ?V?3 for use as anticancer agents 48
Cyclic RGD and iso DGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic ( cis-Beta-ACPC) Scaffolds 47
Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents 47
HuR modulation counteracts lipopolysaccharide response in murine macrophages 47
Tumor Targeting with an isoDGR-Drug Conjugate 46
Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles 46
A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells 45
Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery 45
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors 44
Effective Targeting of DC-SIGN by alpha-Fucosylamide Functionalized Gold Nanoparticles 44
Bisphosphonate-functionalized cyclic Arg-Gly-Asp peptidomimetics 44
Design, Synthesis, and Biological Evaluation of Novel cRGD- Paclitaxel Conjugates for Integrin-Assisted Drug Delivery 43
beta-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate 43
Cyclic isoDGR and RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds are Integrin Antagonists 42
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 42
Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers 42
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate 41
Enhancement of the Uptake and Cytotoxic Activity of Doxorubicin in Cancer Cells by Novel cRGD-Semipeptide-Anchoring Liposomes 40
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 39
Integrin-targeted peptide- and peptidomimetic-drug conjugates for the treatment of tumors. 39
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors 38
Stereodivergent synthesis of 5-aminopipecotic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar alpha(v)beta(3) integrin ligand 36
Functionalised azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition 36
Click chemistry to functionalise peptidomimetics 35
Synthesis and Preliminary Evaluation of Tanshinone Mimic Conjugates for Mechanism of Action Studies 35
Molecular targeting of imaging and drug delivery probes in Atherosclerosis 35
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting alpha(v)beta(3) Integrin and VEGF Receptors 34
Stereoselective synthesis of conformationally constrained cyclohexanediols: A set of molecular scaffolds for the synthesis of glycomimetics 34
Synthesis and cholera toxin binding properties of multivalent GM1 mimics 34
Cyclic RGD-Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor Targeting 33
Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies 32
A synthetic divalent cholera toxin glycocalix[4]arene ligand having higher affinity than natural GM1 oligosaccharide 31
Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-alpha-amanitin conjugates for tumor-targeting 31
Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine-Glycine-Aspartate (RGD) Peptidomimetic-Paclitaxel Conjugates Targeting Integrin alphaVbeta3 30
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin ?V?3 29
Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin (V3) 29
Ganglioside GM1 mimics: Lipophilic substituents improve affinity for cholera toxin 29
Advancement in integrin facilitated drug delivery 29
Mimics of Ganglioside GM1 as Cholera Toxin Ligands: Replacement of the GalNAC Residue 28
Characterization of iron oxide-gold core-shell multifunctional nanoparticles in biomedical imaging 28
Functionalized Cyclic RGD Peptidomimetics: Conjugable ligands for alpha(v)beta(3) Receptor Imaging 27
Cyclic isoDGR Peptidomimetics as Low-Nanomolar alphavbeta3 Integrin Ligands 27
Intramolecular carbohydrate-aromatic interactions and intermolecular van der Waals interactions enhance the molecular recognition ability of GMI glycomimetics for cholera toxin 27
Synthesis of non glycosidic nucleobase-sugar mimetics 27
Insights into the Binding of Cyclic RGD Peptidomimetics to ?5?1 Integrin by using Live-Cell NMR And Computational Studies 27
Mimicking gangliosides by design: Mimics of GM1 headgroup 26
Targeting Integrin ?V?3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario 25
A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids 25
Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and alvhaVbeta3-Integrin Ligands for Tumor Targeting 24
Improved synthesis of both enantiomers of trans-cyclohex-4-ene-1,2-dicarboxylic acid 24
Solid-phase synthesis of combinatorial libraries based on enatiomerically pure (1S,2S,4R,5S)-4,5-dihydroxycyclohexan-1,2-dicarboxylic acid scaffolds 23
Totale 3.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.870
article - articoli 12.244
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 2 0 10 1
2024/20251.305 0 3 88 52 305 120 61 102 11 39 285 239
2025/20261.787 106 229 164 331 342 53 246 70 96 52 46 52
2026/2027376 129 100 147 0 0 0 0 0 0 0 0 0
Totale 3.481